Scientists at the University of Sydney have uncovered a malfunctioning version of the SOD1 protein that clumps inside brain ...

A new study reveals that which side of the body is initially affected by Parkinson's disease can predict cognitive decline ...

Groundbreaking research by Sydney University found a new brain protein involved in Parkinson’s disease and a way to modify it ...

People with Parkinson’s often stay silent about their diagnosis. Here’s what drives that silence and why understanding it ...

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

An active ingredient in cough medicines since 1979 has shown promise as a treatment for neuropsychiatric symptoms in ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

Wolff-Parkinson-White Syndrome is a type of arrhythmia that is commonly diagnosed in young people and infants Here’s all you ...

Parkinson's disease affects approximately 10 million people worldwide. It typically begins asymmetrically, initially ...

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...

A common virus once thought harmless to humans might be linked to Parkinson's disease, a new study says. The germ, Human ...

The earliest known signs of Parkinson’s can include pain, anxiety, balance issues, stiffness, loss of smell, sleep problems ...